New Drug Reduces Tumor Size In Women With Advanced Hereditary Ovarian Or...
Cedars-Sinai participates in international study suggesting that the underlying genetic weakness of cancer, not the organ of origin, is key to effective therapy. Understanding the underlying genetic...
View ArticleOlaparib Shows Promise for Patients With Ovarian Cancer, Even Those Without...
Olaparib, a drug that has shown promise in women with an inherited mutation in their BRCA1 or BRCA2 gene (accounting for about 5%-10% of breast and ovarian cancer cases), has, for the first time, been...
View Article
More Pages to Explore .....
